NCI Needs $107 Million More In FY 1982 Than Asked for Key Programs, R01s And P01s, New Initiatives
In Brief: Surgical Oncology Program Announcements Due For Publication By June; AACR/ASCO Program
“Landmark” Fundings Reported n Interferon Genes, Ovarian And Pancreas Markers
“Great Charlie Moertel Shootout: In Tucson Draws Laughs, Criticism
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - Brian Wolpin celebrates FDA approval of daraxonrasib in pancreatic cancer as the future of the field
- FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants









